Verastem (STU:2VS) E10: €-10.56 (As of Mar. 2026)


STU:2VS Verastem Inc STU:2VS
19 GF Score
Price €3.93
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Verastem E10?

Verastem STU:2VS +1.89% 19 E10 is €-10.56 as of Mar. 2026. GuruFocus rates STU:2VS with a GF Score™ of 19/100 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Verastem's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.398. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-10.56 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 12.50% per year. During the past 5 years, the average E10 Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Verastem was 14.10% per year. The lowest was 9.70% per year. And the median was 12.50% per year.

As of today (2026-07-07), Verastem's current stock price is €3.928. Verastem's E10 for the quarter that ended in Mar. 2026 was €-10.56. Verastem's Shiller PE Ratio of today is .


Verastem  (STU:2VS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Verastem E10 Related Terms


Verastem E10 Historical Data

* Premium members only.

The historical data trend for Verastem's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verastem E10 Chart

Verastem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.52 -14.56 -15.31 -9.77 -10.26

Verastem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.82 -11.44 -10.76 -10.26 -10.56

STU:2VS vs IRD, PALI, GALT: E10 Comparison

For the Biotechnology subindustry, Verastem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verastem Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Verastem's Shiller PE Ratio falls into.


STU:2VS
19GF Score
Verastem Inc STU:2VS
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Verastem E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Verastem's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.398/330.2130*330.2130
=-0.398

Current CPI (Mar. 2026) = 330.2130.

Verastem Quarterly Data

per share eps CPI Adj_EPS
201606 -2.456 241.018 -3.365
201609 -2.245 241.428 -3.071
201612 -3.640 241.432 -4.979
201703 -3.927 243.801 -5.319
201706 -3.845 244.955 -5.183
201709 -6.141 246.819 -8.216
201712 -4.360 246.524 -5.840
201803 -3.990 249.554 -5.280
201806 -3.082 251.989 -4.039
201809 -2.982 252.439 -3.901
201812 -4.008 251.233 -5.268
201903 -5.522 254.202 -7.173
201906 -6.053 256.143 -7.803
201909 -4.467 256.759 -5.745
201912 -5.508 256.974 -7.078
202003 -3.801 258.115 -4.863
202006 -1.492 257.797 -1.911
202009 0.815 260.280 1.034
202012 -1.184 260.474 -1.501
202103 -0.907 264.877 -1.131
202106 -0.996 271.696 -1.211
202109 -1.326 274.310 -1.596
202112 -0.956 278.802 -1.132
202203 -0.981 287.504 -1.127
202206 -1.334 296.311 -1.487
202209 -1.111 296.808 -1.236
202212 -0.916 296.797 -1.019
202303 -0.878 301.836 -0.961
202306 -1.265 305.109 -1.369
202309 -0.703 307.789 -0.754
202312 -0.945 306.746 -1.017
202403 -1.159 312.332 -1.225
202406 -0.288 314.175 -0.303
202409 -0.541 315.301 -0.567
202412 -1.480 315.605 -1.549
202503 -0.888 319.799 -0.917
202506 -0.538 322.561 -0.551
202509 -1.150 324.800 -1.169
202512 -0.248 324.054 -0.253
202603 -0.398 330.213 -0.398

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-10.56 mean?
Verastem (STU:2VS) has a E10 of €-10.56 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Verastem and its competitors.
Is Verastem's E10 too high?
Verastem's current E10 is €-10.56. Overall, Verastem has a GF Score™ of 19/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verastem's E10 compare to IRD and PALI?
Verastem's E10 of €-10.56 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Verastem and its competitors. Verastem's current E10 is €-10.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verastem stock overvalued right now?
Based on GuruFocus' analysis, Verastem (STU:2VS) is currently considered Possible Value Trap. The current E10 is €-10.56. Verastem's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Verastem (STU:2VS), the current E10 is €-10.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Verastem Business Description

Other Exchanges VSTM:USA0LOV:UK
Address 117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
19GF Score

Get the complete analysis for STU:2VS

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.93
Price